Limited transscleral cyclophotocoagulation for silicone oil-induced glaucoma in eyes with good visual potential

Table 2 Demographic and clinical details, n (%)

Parameter	Value
Median age at TSCPC in years	28.3 (15-34)
Sex as male: Female	10:2
One-eyed patients	5 (41.7)
Eyes with prior SOR	9 (75)
Non-glaucoma intraocular surgeries	2 (1-2)
Duration between VR surgery and high IOP in months	4.8 (3.8-11.1)
Pre-operative glaucoma surgery	2 (16.7) both AGV
Lens status as Phakic: Pseudophakic: Aphakic	1:3:8
Interval between SOI and TSCPC in months, n = 12	9 (5-19)
Interval between SOI and TSCPC in months, n = 3 without SOR	18 (5-97)
Interval between SOI and TSCPC in months, n = 9 with SOR	7 (5-12)
Duration between VR surgery and SOR in months, n = 9	3 (2.1-3.9)
Interval between SOR and TSCPC in months, n = 9	3.4 (2.3-5.5)
Pre-operative vision as logMAR	1.06 (0.6-1.2)
Pre-operative IOP in mmHg	29.5 (17-40)
Pre-operative CDR	0.8 (0.5-0.9)
Pre-operative AGM	4 (3-5)
Follow-up duration in months	21.5 (14.2-31.6)

Data are presented as n (%) or median (interquartile range). AGM: Anti-glaucoma medication; AGV: Ahmed glaucoma valve; CDR: Cup-to-disc ratio; IOP: Intraocular pressure; IQR: Interquartile range; LogMAR: Logarithm of the minimum angle of resolution; SOI: Silicone oil injection; SOR: Silicone oil removal; TSCPC: Transscleral cyclophotocoagulation; VR: Vitreoretinal.